Challenges and Recommendations to  Recruiting Women Who Do Not Adhere  to Follow-Up Gynecological Care

LaShawn Wordlaw-Stinson; Sierra Jones; Shaneese Little; Laura Fish; Adriana Vidal; Cathrine Hoyo; Jennifer S. Smith; Patricia G. Moorman

doi:10.4236/ojpm.2014.43017

Home > Journals > Medicine & Healthcare > OJPM

Open Journal of Preventive Medicine > Vol.4 No.3, March 2014

Challenges and Recommendations to Recruiting Women Who Do Not Adhere to Follow-Up Gynecological Care ()

LaShawn Wordlaw-Stinson, Sierra Jones, Shaneese Little, Laura Fish, Adriana Vidal, Cathrine Hoyo, Jennifer S. Smith, Patricia G. Moorman

Department of Public Health Education, North Carolina Central University, Durham, USA.
Duke University Medical Center, Durham, USA.
University of North Carolina-Chapel Hill, Durham, USA.

DOI: 10.4236/ojpm.2014.43017 PDF HTML XML 3,138 Downloads 4,321 Views Citations

Abstract

Purpose: Non-adherence to recommended follow-up visits after an abnormal cytological finding is associated with poorer outcomes and higher health care costs. The purpose of this paper is to describe the challenges when examining reasons for non-adherence to cervical cancer screening follow-up and to discuss the recommendations to overcome those challenges. Methods: We conducted a telephone survey with two subgroups of women: 1) those which adhered to recommended follow-up care after an abnormal Pap test, and 2) those which did not adhere. Results: The follow-up accrual among non-adherent women lagged behind that of adherers. We were able to contact and conduct a survey with 51% of the adherers and 26% of the non-adherers. The challenges in studying non-adherent women were related to several distinct factors: 1) the definition of non-adherence, 2) the availability of alternate contact information, 3) the amount and type of financial incentives, and 4) the availability of staffing. We describe strategies employed to increase the accrual of non-adherent women. Discussion: This paper describes four recommendations that may play a role in understanding and reducing non-adherence to follow-up gynecological care.

Keywords

Non-Adherence; Patient Compliance; Cervical Cancer; Cervical Intraepithelial Neoplasia; Cancer Screening; Abnormal Pap Smear; Abnormal Pap Test; HPV; Patient Navigation

Share and Cite:

Wordlaw-Stinson, L. , Jones, S. , Little, S. , Fish, L. , Vidal, A. , Hoyo, C. , Smith, J. and Moorman, P. (2014) Challenges and Recommendations to Recruiting Women Who Do Not Adhere to Follow-Up Gynecological Care. Open Journal of Preventive Medicine, 4, 123-128. doi: 10.4236/ojpm.2014.43017.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Howlader, N., Noone, A.M., Krapcho, M., Garshell, J., Neyman, N., Altekruse, S.F., Kosary, C.L., Yu, M., Ruhl, J., Tatalovich, Z., Cho, H., Mariotto, A., Lewis, D.R., Chen, H.S., Feuer, E.J. and Cronin, K.A., Eds. (2013) SEER Cancer Statistics Review, 1975-2010. National Cancer Institute, Bethesda. http://seer.cancer.gov/statfacts/html/cervix.html
[2]	Leyden, W.A., Manos, M.M., Geiger, A.M., Weinmann, S., Mouchawar, J., Bischoff, K., et al. (2005) Cervical Cancer in Women with Comprehensive Health Care Access: Attributable Factors in the Screening Process. Journal of National Cancer Institute, 97, 675-683. http://dx.doi.org/10.1093/jnci/dji115
[3]	Xu, F., Town, M., Ballus, L.S., Bartoli, W.P., Murphy, W., Chowdhury, P.P., Garvin, W.S., Pierannunzi, C., Zhong, Y., Salandy, S.W., Jones, C.W. and Crawford, C.A. (2013) Surveillance for Certain Health Behaviors among States and Selected Local Areas—United States, 2010 Centers for Disease Control and Prevention. MMWR, 62, 107.
[4]	Lane, D. (1983) Compliance with Referrals from a Cancer Screening Project. Journal of Family Practice, 17, 811-817.
[5]	Ellman, R. (1990) Problems of Follow-Up for Abnormal Cervical Smears: Discussion Paper. Journal of R Social Medicine, 83, 94-95.
[6]	Kinlen, L.J. and Spriggs, A.I. (1978) Women with Positive Cervical Smears but without Surgical Interventions: A Follow-Up Study. Lancet, 2, 463-465. http://dx.doi.org/10.1016/S0140-6736(78)91457-5
[7]	Schiffman, M. and Adrianza, M.E. (2000) ASCUS_LSIL Triage Study. Design, Methods and Characteristics of Trial Participants. Acta Cytologica, 44, 726-742. http://dx.doi.org/10.1159/000328554
[8]	Jones, B.A. and Novis, D.A. (2000) Follow-Up of Abnormal Gynecologic Cytology: A College of American Pathologists Q-Probes Study of 16132 Cases from 306 Laboratories. Archives of Pathology & Laboratory Medicine, 124, 665-671.
[9]	Janerich, D.T., Hadjimichael, O., Schwartz, P.E., Lowell, D.M., Meigs, J.W., Merino, M.J. Flannery, J.T. and Polednak, A.P. (1995) The Screening Histories of Women with Invasive Cervical Cancer, Connecticut. American Journal of Public Health, 85, 791-796. http://dx.doi.org/10.2105/AJPH.85.6.791
[10]	Ting, J., Kruzikas, D.T. and Smith, J.S. (2010) A Global Review of Age-Specific and Overall Prevalence of Cervical Lesions. International Journal of Gynecological Care, 20, 1244-1249. http://dx.doi.org/10.1111/IGC.0b013e3181f16c5f
[11]	Fish, L.J., Moorman, P.G., Wordlaw-Stinson, L., Vidal, A., Smith, J. and Hoyo, C. (in Press) HPV and Cervical Cancer Knowledge Associated with Greater Adherence to Follow-Up Colposcopy. American Journal of Health Education.
[12]	Bissonnette, J. (2008) Adherence: A Concept Analysis. Journal of Advanced Nursing, 63, 634-643. http://dx.doi.org/10.1111/j.1365-2648.2008.04745.x
[13]	Haynes, R.B., Yoa, X., Degani, A., Kripalani, S., Garg, A. and McDonald, H.P. (2005) Interventions to Enhance Medication Adherence (Review). Cochrane Database of Systematic Reviews, 4, 1-77.
[14]	Saslow, D., Solomon, D., Lawson, H., Killackey, M., et al. (2012) American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer. A Cancer Journal for Clinicians, 62, 147-172.
[15]	Marcus, A.C., Crane, L.A., Kaplan, C.P., Reading, A.E., Savage, E., Gunning, J., Bernstein, G. and Berek, J.S. (1992) Improving Adherence to Screening Follow-Up among Women with Abnormal Pap Smears: Results from a Large Clinic-Based Trial of Three Intervention Strategies. Medical Care, 30, 216-230. http://dx.doi.org/10.1097/00005650-199203000-00004
[16]	American Society for Colposcopy and Cervical Pathology (2013) Management and Screening Guidelines. http://www.asccp.org/ConsensusGuidelines/tabid/7436/Default.aspx
[17]	Khanna, N. and Phillips, D. (2001) Adherence to Care Plan in Women with Abnormal Papanicolaou Smears: A Review of Barriers and Interventions. Journal of the American Board of Family Practice, 14, 123-130.
[18]	Kaplan, C.P., Bastani, R., Belin, T.R., Marcus, A., Nasseri, K. and Hu, M. (2000) Improving Follow-Up after Abnormal Pap Smear Results from a Quasi-Experimental Intervention Study. Journal of Women’s Health, 9, 779-790.
[19]	Marcus, A.C., Kaplan, C.P., Crane, L.A., Berek, J.S., Bernstein, G., Gunning, J. and McClatchey, M.W. (1998) Reducing Loss-To-Follow-Up among Women with Abnormal Pap Smears. Results from a Randomized Trial Testing an Intensive Follow-Up Protocol and Economic Incentives. Medical Care, 36, 397-410. http://dx.doi.org/10.1097/00005650-199803000-00015
[20]	O’Malley, A.S., Samuel, D., Bond, A. and Carrier, E. (2012) After-Hours Care and Its Coordination with Primary Care in the US. Journal of General Internal Medicine, 27, 1406-1415. http://dx.doi.org/10.1007/s11606-012-2087-4